C07K 14/70567
Nuclear receptors
Official title: {Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors}
C07K14/70567 (Nuclear receptors) appears on 260 US grants and 315 published applications in this corpus.
Search patents in C07K- Granted patents
- 260
- Published applications
- 315
- Assignees
- 188
- Inventors
- 674
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 15 | 0 |
| 1998 | 12 | 0 |
| 1999 | 15 | 0 |
| 2000 | 5 | 0 |
| 2001 | 11 | 4 |
| 2002 | 14 | 34 |
| 2003 | 13 | 36 |
| 2004 | 11 | 27 |
| 2005 | 7 | 16 |
| 2006 | 19 | 33 |
| 2007 | 12 | 14 |
| 2008 | 8 | 13 |
| 2009 | 7 | 11 |
| 2010 | 9 | 7 |
| 2011 | 8 | 14 |
| 2012 | 9 | 11 |
| 2013 | 7 | 8 |
| 2014 | 7 | 5 |
| 2015 | 3 | 8 |
| 2016 | 8 | 2 |
| 2017 | 3 | 7 |
| 2018 | 1 | 5 |
| 2019 | 6 | 9 |
| 2020 | 3 | 8 |
| 2021 | 8 | 11 |
| 2022 | 5 | 6 |
| 2023 | 2 | 7 |
| 2024 | 4 | 10 |
| 2025 | 5 | 5 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PPARδ activator8 Apr 2025US 12,268,672 B2Japan Science and Technology Agency
- Compositions and methods of treating cancer with chimeric antigen receptors1 Apr 2025US 12,264,190 B2AstraZeneca AB
- Model for high-throughput screening of endocrine disruptor and method for screening same25 Feb 2025US 12,237,054 B2Nanjing University
- Compositions and methods for treating type 1 and type 2 diabetes and related disorders4 Feb 2025US 12,213,999 B2The Salk Institute for Biological Studies
- Protein, and therapeutic and cosmetic uses thereof14 Jan 2025US 12,195,502 B2Quorum Innovations, LLC
- Transcriptional therapy based-lipid nanoparticles and mrna for the treatment of end-stage liver disease27 Aug 2026US 2026/0250351 A1The Trustees of the University of Pennsylvania
- Polynucleotides targeting nr4a3 and uses thereof26 Mar 2026US 2026/0083846 A1Lyell Immunopharma, Inc.
- Method for secretory production of proteins12 Mar 2026US 2026/0071227 A1Ajinomoto Co., Inc.
- Agent for treating or preventing a dominantly-inherited disease19 Feb 2026US 2026/0048074 A1The University of Adelaide
- Binding molecules to tumor associated macrophages and methods of use13 Nov 2025US 2025/0345388 A1Sanford Burnham Prebys Medical Discovery Institute
Most cited
By later US patents
- Retinoic acid receptor method226US 4,981,784 AThe Salk Institute for Biological Studies · 1991
- Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors129US 5,466,861 ALa Jolla Cancer Research Foundation · 1995
- Process for identifying modulators of ABC1 activity116US 6,617,122 B1Xenon Genetics Inc. · 2003
- Transgenic mouse for targeted recombination mediated by modified Cre-ER97US 7,112,715 B2Gie-Cerbm, Centre Europeen de Recherche en Biologie et en Medecine (GIE) · 2006
- Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand87US 5,880,333 ANovartis Finance Corporation · 1999